News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,409 Results
Type
Article (88069)
Company Profile (825)
Press Release (782496)
Multimedia
Podcasts (200)
Webinars (29)
Section
Business (233309)
Career Advice (4149)
Deals (39887)
Drug Delivery (151)
Drug Development (91449)
Employer Resources (205)
FDA (18408)
Job Trends (17434)
News (398016)
Policy (39978)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3016)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (154)
Alliances (56982)
ALS (183)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (356)
Approvals (18595)
Artificial intelligence (650)
Autoimmune disease (177)
Automation (41)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (490)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (680)
Cancer (5145)
Cardiovascular disease (455)
Career advice (3573)
Career pathing (42)
CAR-T (313)
CDC (59)
Celiac Disease (2)
Cell therapy (854)
Cervical cancer (38)
Clinical research (77174)
Collaboration (1876)
Company closure (5)
Compensation (1194)
Complete response letters (75)
COVID-19 (2996)
CRISPR (100)
C-suite (914)
Cystic fibrosis (155)
Data (6407)
Decentralized trials (2)
Denatured (74)
Depression (153)
Diabetes (542)
Diagnostics (7262)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (315)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (247)
Earnings (100371)
Editorial (67)
Employer branding (25)
Employer resources (174)
Events (135317)
Executive appointments (1048)
FDA (21665)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1591)
Gene editing (220)
Generative AI (69)
Gene therapy (691)
GLP-1 (1146)
Government (5459)
Grass and pollen (8)
Guidances (387)
Healthcare (20960)
HIV (66)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (302)
Immuno-oncology (66)
Indications (111)
Infectious disease (3296)
Inflammatory bowel disease (208)
Inflation Reduction Act (17)
Influenza (127)
Intellectual property (258)
Interviews (816)
IPO (17966)
IRA (61)
Job creations (5201)
Job search strategy (2867)
JPM (71)
Kidney cancer (18)
Labor market (96)
Layoffs (661)
Leadership (41)
Legal (10163)
Liver cancer (99)
Longevity (16)
Lung cancer (692)
Lymphoma (386)
Machine learning (45)
Management (66)
Manufacturing (881)
MASH (178)
Medical device (15061)
Medtech (15118)
Mergers & acquisitions (23011)
Metabolic disorders (1436)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (366)
Neuropsychiatric disorders (105)
Neuroscience (3165)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5118)
Now hiring (68)
Obesity (699)
Opinion (337)
Ovarian cancer (171)
Pain (218)
Pancreatic cancer (239)
Parkinson's disease (303)
Partnered (39)
Patents (522)
Patient recruitment (513)
Peanut (61)
People (67016)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23847)
Phase 2 (33490)
Phase 3 (25222)
Pipeline (5435)
Policy (343)
Postmarket research (3554)
Preclinical (10701)
Press Release (72)
Prostate cancer (254)
Psychedelics (58)
Radiopharmaceuticals (305)
Rare diseases (946)
Real estate (7442)
Recruiting (81)
Regulatory (29153)
Reports (68)
Research institute (2733)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (86)
Schizophrenia (161)
Series A (263)
Series B (204)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1171)
Venture capital (100)
Weight loss (481)
Women's health (96)
Worklife (22)
Date
Today (206)
Last 7 days (645)
Last 30 days (2322)
Last 365 days (32926)
2026 (3721)
2025 (33229)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (51624)
Australia (9067)
California (11786)
Canada (3381)
China (1200)
Colorado (501)
Connecticut (512)
Delaware (354)
Europe (118638)
Florida (1739)
Georgia (378)
Hawaii (4)
Idaho (68)
Illinois (981)
India (73)
Indiana (554)
Iowa (24)
Japan (446)
Kansas (134)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1475)
Massachusetts (8662)
Michigan (368)
Minnesota (675)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (86)
New Jersey (3162)
New Mexico (33)
New York (3109)
North Carolina (1637)
North Dakota (10)
Northern California (5666)
Ohio (360)
Oklahoma (23)
Oregon (55)
Pennsylvania (2349)
Puerto Rico (25)
Rhode Island (50)
South America (1665)
South Carolina (68)
South Dakota (1)
Southern California (4553)
Tennessee (180)
Texas (1857)
United States (42463)
Utah (352)
Vermont (1)
Virginia (296)
Washington D.C. (88)
Washington State (989)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
There are 871,409 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, uniQure and many more.
February 13, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Evommune Announces $125 Million Private Placement
February 12, 2026
·
5 min read
Press Releases
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
February 12, 2026
·
5 min read
Press Releases
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
February 12, 2026
·
5 min read
Press Releases
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
February 12, 2026
·
2 min read
Press Releases
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer
February 12, 2026
·
8 min read
Press Releases
CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai
February 12, 2026
·
3 min read
Press Releases
GE HealthCare announces cash dividend for first quarter of 2026
February 12, 2026
·
1 min read
Press Releases
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
·
1 min read
Press Releases
Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update
February 12, 2026
·
11 min read
1 of 87,141
Next
